NEW YORK (GenomeWeb) – Investment bank BTIG initiated coverage of NanoString Technologies on Monday with a Buy rating, saying new market opportunities could await the company's nCounter platform. 

BTIG analyst Dane Leone had a price target of $16 on NanoString's stock and estimated the company's full-year 2015 revenues at $61 million with a loss per share of $1.90. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.